Moving statistics beyond the individual clinical trial: applying decision science to optimize a clinical development plan
暂无分享,去创建一个
This paper describes how simple decision science techniques can be used to optimize the clinical development plan for a given compound. Using a case study from the stroke therapeutic area it is shown how methods such as decision trees can be utilized to describe, and adjudicate on, individual development plans. Terminology pertinent to decision sciences is described and areas where it is recommended statisticians should focus are highlighted. Copyright © 2005 John Wiley & Sons, Ltd.
[1] G G Enas,et al. Enhancing the value delivered by the statistician throughout drug discovery and development: putting statistical science into regulated pharmaceutical innovation , 2001, Statistics in medicine.
[2] Stephen Senn,et al. Statistical Issues in Drug Development , 1997 .
[3] Stephen Senn,et al. Examples of option values in drug development , 2003 .
[4] S. Perera,et al. Stroke Impact Scale-16 , 2003, Neurology.